215 related articles for article (PubMed ID: 22286759)
1. The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.
Belguise K; Milord S; Galtier F; Moquet-Torcy G; Piechaczyk M; Chalbos D
Oncogene; 2012 Nov; 31(47):4889-97. PubMed ID: 22286759
[TBL] [Abstract][Full Text] [Related]
2. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D
Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489
[TBL] [Abstract][Full Text] [Related]
3. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
4. SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway.
Li Y; Hu J; Vita R; Sun B; Tabata H; Altman A
EMBO J; 2004 Mar; 23(5):1112-22. PubMed ID: 14988727
[TBL] [Abstract][Full Text] [Related]
5. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.
Belguise K; Sonenshein GE
J Clin Invest; 2007 Dec; 117(12):4009-21. PubMed ID: 18037997
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
[TBL] [Abstract][Full Text] [Related]
7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C theta (PKCtheta)-dependent phosphorylation of PDK1 at Ser504 and Ser532 contributes to palmitate-induced insulin resistance.
Wang C; Liu M; Riojas RA; Xin X; Gao Z; Zeng R; Wu J; Dong LQ; Liu F
J Biol Chem; 2009 Jan; 284(4):2038-44. PubMed ID: 19047061
[TBL] [Abstract][Full Text] [Related]
9. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.
Chen H; Zhu G; Li Y; Padia RN; Dong Z; Pan ZK; Liu K; Huang S
Cancer Res; 2009 Dec; 69(24):9228-35. PubMed ID: 19920183
[TBL] [Abstract][Full Text] [Related]
10. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells.
Ghaffari-Tabrizi N; Bauer B; Villunger A; Baier-Bitterlich G; Altman A; Utermann G; Uberall F; Baier G
Eur J Immunol; 1999 Jan; 29(1):132-42. PubMed ID: 9933094
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Bruton's tyrosine kinase and protein kinase Ctheta in platelets. Cross-talk between tyrosine and serine/threonine kinases.
Crosby D; Poole AW
J Biol Chem; 2002 Mar; 277(12):9958-65. PubMed ID: 11788586
[TBL] [Abstract][Full Text] [Related]
13. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C.
Villalba M; Bi K; Hu J; Altman Y; Bushway P; Reits E; Neefjes J; Baier G; Abraham RT; Altman A
J Cell Biol; 2002 Apr; 157(2):253-63. PubMed ID: 11956228
[TBL] [Abstract][Full Text] [Related]
14. PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.
Sancho V; Berna MJ; Thill M; Jensen RT
Biochim Biophys Acta; 2011 Dec; 1813(12):2145-56. PubMed ID: 21810446
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
16. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.
Villunger A; Ghaffari-Tabrizi N; Tinhofer I; Krumböck N; Bauer B; Schneider T; Kasibhatla S; Greil R; Baier-Bitterlich G; Uberall F; Green DR; Baier G
Eur J Immunol; 1999 Nov; 29(11):3549-61. PubMed ID: 10556809
[TBL] [Abstract][Full Text] [Related]
17. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
18. PKCθ-mediated serine/threonine phosphorylations of FAK govern adhesion and protrusion dynamics within the lamellipodia of migrating breast cancer cells.
Chadelle L; Liu J; Choesmel-Cadamuro V; Karginov AV; Froment C; Burlet-Schiltz O; Gandarillas S; Barreira Y; Segura C; Van Den Berghe L; Czaplicki G; Van Acker N; Dalenc F; Franchet C; Hahn KM; Wang X; Belguise K
Cancer Lett; 2022 Feb; 526():112-130. PubMed ID: 34826547
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.
Gruda MC; Kovary K; Metz R; Bravo R
Oncogene; 1994 Sep; 9(9):2537-47. PubMed ID: 8058317
[TBL] [Abstract][Full Text] [Related]
20. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28.
Khoshnan A; Bae D; Tindell CA; Nel AE
J Immunol; 2000 Dec; 165(12):6933-40. PubMed ID: 11120819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
